Stock Analiz

Lemaitre Vascular Inc. (LMAT) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Lemaitre Vascular’s revenue went from $89M in fiscal 2016 to $250M in fiscal 2025, growth of about 12.1% a year.

Net income in fiscal 2025 was $58M, a net margin of 23.1%; the highest of the period.

Over the twelve months to September 30, 2026, revenue was $269M and net income $63M.

Free cash flow was $74M in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count rose 19% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $89M162017: $101M172018: $106M182019: $117M192020: $129M202021: $154M212022: $162M222023: $193M232024: $220M242025: $250M25$250M
Net income
2016: $11M162017: $17M172018: $23M182019: $18M192020: $21M202021: $27M212022: $21M222023: $30M232024: $44M242025: $58M25$58M
Free cash flow
2016: $14M162017: $16M172018: $16M182019: $10M192020: $32M202021: $30M212022: $22M222023: $29M232024: $37M242025: $74M25$74M
EPS (diluted)
2016: $0.55162017: $0.86172018: $1.13182019: $0.88192020: $1.04202021: $1.25212022: $0.93222023: $1.34232024: $1.93242025: $2.5225$2.52

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$269M$250M$220M$193M$162M$154M$129M$117M$106M$101M$89M
Gross profit$194M$179M$151M$127M$105M$101M$85M$80M$74M$71M$63M
Operating income$75M$68M$52M$37M$27M$36M$29M$21M$28M$21M$16M
Net income$63M$58M$44M$30M$21M$27M$21M$18M$23M$17M$11M
EPS (diluted)$2.75$2.52$1.93$1.34$0.93$1.25$1.04$0.88$1.13$0.86$0.55
R&D$17M$14M$16M$17M$13M$12M$10M$9M$8M$7M$6M
Revenue growth—+13.5%+13.6%+19.7%+4.7%+19.4%+10.3%+11.1%+4.7%+13.1%+13.8%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$76M$81M$44M$37M$25M$35M$35M$14M$20M$23M$17M
Capital spending-$9M-$7M-$7M-$7M-$3M-$5M-$3M-$4M-$3M-$6M-$3M
Free cash flow$67M$74M$37M$29M$22M$30M$32M$10M$16M$16M$14M
Dividends paid$22M$18M$14M$12M$11M$9M$8M$7M$5M$4M$3M
Buybacks$2M$2M$2M$853000$642000$802000$570000$683000$741000$778000$311000
Stock-based pay$8M$8M$7M$5M$4M$3M$3M$3M$2M$2M$2M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$359M$300M$105M$83M$70M$27M$12M$26M$19M$24M
Debt—$186M$186M$19M$17M$16M$52M$16M———
Equity—$394M$337M$298M$268M$254M$173M$148M$130M$110M$88M
Total assets—$616M$552M$347M$310M$293M$253M$188M$153M$126M$102M
Shares (diluted)23M23M23M22M22M21M20M20M20M20M19M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin72.0%71.5%68.6%65.7%64.9%65.6%65.4%68.1%70.0%70.1%70.6%
Operating margin27.7%27.2%23.8%19.0%16.6%23.6%22.2%18.1%26.7%20.9%18.3%
Net margin23.5%23.1%20.0%15.6%12.8%17.4%16.4%15.3%21.7%17.0%11.9%
FCF margin24.9%29.8%16.9%15.2%13.7%19.6%24.6%8.9%15.6%16.3%15.8%
ROIC—9.0%7.7%8.8%7.1%10.6%9.9%10.7%17.5%15.7%12.2%
ROE—14.7%13.1%10.1%7.7%10.6%12.3%12.1%17.6%15.7%12.1%

Frequently asked questions

What is Lemaitre Vascular’s annual revenue?

$250M in fiscal 2025 and $269M over the twelve months to September 30, 2026.

How much profit does Lemaitre Vascular make?

Net income was $58M in fiscal 2025 (net margin 23.1%).

Is Lemaitre Vascular’s revenue growing?

Yes: revenue rose 13.5% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.